AzTrials
AzTrials

Dental Restoration Failure of Marginal IntegrityNCT02572570

Clinical Investigation of a New Bulk Fill Composite Resin in the Restoration of Posterior Teeth

A study testing Filtek Bulk Fill Posterior and Filtek Supreme Ultra in people with Dental Restoration Failure of Marginal Integrity and Dental Caries, run by University of North Carolina, Chapel Hill at 1 site in United States.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

Polymerization shrinkage remains one of the primary disadvantages of composite resin restorative materials (tooth-colored fillings). To minimize the effects of polymerization shrinkage in the restorative treatment, the 3M ESPE company has developed a composite resin called Filtek Bulk Fill Posterior Restorative. Read more about this study

Who is it for?
Ages 18 to 99 yearsHealthy volunteers can take part
What is being tested?
Filtek Bulk Fill Posterior and Filtek Supreme Ultra
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
27 participants
Where
1 siteUnited States
Study dates
Dec 2015to 5 Dec 2019
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 99 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Be 18 years of age and older
  • Have a pair of similar cavities or failed dental fillings in vital permanent posterior teeth requiring treatment
  • Be capable of giving written informed consent.

Who cannot join

  • Have a self-reported history of any adverse reaction to materials of the types to be evaluated
  • Have a medical or dental history that could possibly complicate the provision of the proposed treatment and/or influence the behavior and performance of the treatment in clinical service.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University of North Carolina at Chapel Hill School of Dentistry

    Chapel Hill, North Carolina, 27599

Other trials in United States

About this study

Polymerization shrinkage remains one of the primary disadvantages of composite resin restorative materials (tooth-colored fillings). To minimize the effects of polymerization shrinkage in the restorative treatment, the 3M ESPE company has developed a composite resin called Filtek Bulk Fill Posterior Restorative. Its decreased polymerization shrinkage and properties allow the material to be inserted in one single increment, expediting treatment. This clinical trial is designed to evaluate the performance of the new bulk fill composite resin in Class II (two-surface posterior) fillings.

Being tested
Filtek Bulk Fill Posterior, Filtek Supreme Ultra
Keywords
Adult dental care
Medical subject headings
Dental Caries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Filtek Bulk Fill PosteriorDevice

    Also called Dental filling

    Tooth (teeth) affected by dental caries or with an existing defective filling restored using the materials listed (Filtek Bulk Fill Posterior). Procedures done using local anesthesia and following ordinary restorative techniques.

  • Filtek Supreme UltraDevice

    Also called Dental filling

    Tooth (teeth) affected by dental caries or with an existing defective filling restored using the materials listed (Filtek Supreme Ultra). Procedures done using local anesthesia and following ordinary restorative techniques.

Study groups in NCT02572570
Study groupRoleWhat they receive
Posterior Composite Resin RestorationExperimentalParticipants will receive two commercially available tooth-colored restorative materials used for direct restoration as per manufacturer's instructions.
Receives: Device: Filtek Bulk Fill Posterior; Device: Filtek Supreme Ultra

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Restoration Percent Success at Day 1

    The World Dental Federation (FDI) rates 16 categories on a scale of 1 to 5 with 1 being "Clinically Excellent" and 5 being "Clinically Poor". Scores 1-3 were considered clinically acceptable while scores 4 and 5 were considered failures. Cases were considered successful if each of the 16 following FDI criteria presented an individual score of 3 or less:

    A.Esthetic Properties Surface lustre [Item 1] Surface staining [Item 2] Color stability and translucency [Item 3] Anatomic form [Item 4] B.Functional Properties Fractures and retention [Item 5] Marginal adaptation [Item 6] Wear [Item 7] Contact point/food impact [Item 8] Radiographic examination [Item 9] Patient's view [Item 10] C.Biological Properties Postoperative (hyper)sensitivity and tooth vitality [Item 11] Recurrence of caries, erosion, abfraction [Item 12] Tooth integrity [Item 13] Periodontal response [Item 14] Adjacent mucosa [Item 15] Oral and general health [Item 16]

    Measured: Assessed immediately post restoration placement completion

  2. Restoration Percent Success at Year 1

    The World Dental Federation (FDI) rates 16 categories on a scale of 1 to 5 with 1 being "Clinically Excellent" and 5 being "Clinically Poor". Scores 1-3 were considered clinically acceptable while scores 4 and 5 were considered failures. Cases were considered successful if each of the 16 following FDI criteria presented an individual score of 3 or less:

    A.Esthetic Properties

    • Surface lustre [Item 1]
    • Surface staining [Item 2]
    • Color stability and translucency [Item 3]
    • Anatomic form [Item 4]

    B.Functional Properties

    • Fractures and retention [Item 5]
    • Marginal adaptation [Item 6]
    • Wear [Item 7]
    • Contact point/food impact [Item 8]
    • Radiographic examination [Item 9]
    • Patient's view [Item 10]

    C.Biological Properties

    • Postoperative (hyper)sensitivity and tooth vitality [Item 11]
    • Recurrence of caries, erosion, abfraction [Item 12]
    • Tooth integrity [Item 13]
    • Periodontal response [Item 14]
    • Adjacent mucosa [Item 15]
    • Oral and general health [Item 16]

    Measured: Year 1

  3. Restoration Percent Success at Year 2

    The FDI rates 16 categories on a scale of 1 to 5 with 1 being "Clinically Excellent" and 5 being "Clinically Poor". Scores 1-3 were considered clinically acceptable while scores 4 and 5 were considered failures. Cases were considered successful if each of the 16 following FDI criteria presented an individual score of 3 or less:

    A.Esthetic Properties

    • Surface lustre [Item 1]
    • Surface staining [Item 2]
    • Color stability and translucency [Item 3]
    • Anatomic form [Item 4]

    B.Functional Properties

    • Fractures and retention [Item 5]
    • Marginal adaptation [Item 6]
    • Wear [Item 7]
    • Contact point/food impact [Item 8]
    • Radiographic examination [Item 9]
    • Patient's view [Item 10]

    C.Biological Properties

    • Postoperative (hyper)sensitivity and tooth vitality [Item 11]
    • Recurrence of caries, erosion, abfraction [Item 12]
    • Tooth integrity [Item 13]
    • Periodontal response [Item 14]
    • Adjacent mucosa [Item 15]
    • Oral and general health [Item 16]

    Measured: Year 2

  4. Restoration Percent Success at Year 3

    The FDI rates 16 categories on a scale of 1 to 5 with 1 being "Clinically Excellent" and 5 being "Clinically Poor". Scores 1-3 were considered clinically acceptable while scores 4 and 5 were considered failures. Cases were considered successful if each of the 16 following FDI criteria presented an individual score of 3 or less:

    A.Esthetic Properties

    • Surface lustre [Item 1]
    • Surface staining [Item 2]
    • Color stability and translucency [Item 3]
    • Anatomic form [Item 4]

    B.Functional Properties

    • Fractures and retention [Item 5]
    • Marginal adaptation [Item 6]
    • Wear [Item 7]
    • Contact point/food impact [Item 8]
    • Radiographic examination [Item 9]
    • Patient's view [Item 10]

    C.Biological Properties

    • Postoperative (hyper)sensitivity and tooth vitality [Item 11]
    • Recurrence of caries, erosion, abfraction [Item 12]
    • Tooth integrity [Item 13]
    • Periodontal response [Item 14]
    • Adjacent mucosa [Item 15]
    • Oral and general health [Item 16]

    Measured: Year 3

  5. Restoration Percent Success at Year 5

    The FDI rates 16 categories on a scale of 1 to 5 with 1 being "Clinically Excellent" and 5 being "Clinically Poor". Scores 1-3 were considered clinically acceptable while scores 4 and 5 were considered failures. Cases were considered successful if each of the 16 following FDI criteria presented an individual score of 3 or less:

    A.Esthetic Properties

    • Surface lustre [Item 1]
    • Surface staining [Item 2]
    • Color stability and translucency [Item 3]
    • Anatomic form [Item 4]

    B.Functional Properties

    • Fractures and retention [Item 5]
    • Marginal adaptation [Item 6]
    • Wear [Item 7]
    • Contact point/food impact [Item 8]
    • Radiographic examination [Item 9]
    • Patient's view [Item 10]

    C.Biological Properties

    • Postoperative (hyper)sensitivity and tooth vitality [Item 11]
    • Recurrence of caries, erosion, abfraction [Item 12]
    • Tooth integrity [Item 13]
    • Periodontal response [Item 14]
    • Adjacent mucosa [Item 15]
    • Oral and general health [Item 16]

    Measured: Year 5

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Oct 2015 (estimated)
  2. Study startDec 2015
  3. Primary completion5 Dec 2019
  4. Study completion5 Dec 2019

Why it stopped: Attrition rate complicated by COVID-19 led to termination.

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
27 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02572570
Sponsor's protocol ID
14-3097
Status last verified
Oct 2020
First submitted
21 Sep 2015
Last updated
19 Dec 2020
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing Filtek Bulk Fill Posterior and Filtek Supreme Ultra in people with Dental Restoration Failure of Marginal Integrity and Dental Caries, run by University of North Carolina, Chapel Hill at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 19 Dec 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 19 Dec 2020). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Restoration Percent Success at Day 1 (time frame: Assessed immediately post restoration placement completion). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Dec 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in